Medicare Enrolled
Dr. Peter Nalos, MD
Cardiovascular Disease · Bakersfield, CA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nalos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nalos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nalos
Dr. Peter Nalos is a cardiovascular disease specialist in Bakersfield, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Nalos performed 10,484 Medicare services across 3,914 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nalos received a total of $10,309 from 31 pharmaceutical and/or device companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nalos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 6% volume in CA
$10,309 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,484
Medicare services
Top 6% in CA for cardiovascular disease
3,914
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~582 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
1,302 | $18 | $58 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,100 | $0 | $5 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
1,053 | $31 | $50 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
959 | $22 | $64 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
848 | $65 | $154 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
804 | $19 | $60 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
767 | $59 | $124 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
412 | $42 | $78 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
350 | $28 | $117 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
340 | $42 | $150 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
262 | $19 | $72 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
216 | $73 | $165 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $41 | $93 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 168 | $408 | $1,000 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
139 | $4 | $40 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
135 | $10 | $36 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
132 | $7 | $26 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
130 | $82 | $180 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
100 | $36 | $100 |
| Programming of single lead implantable defibrillator system Adjustment and testing of the settings for a single-lead implantable cardioverter-defibrillator (ICD) to ensure proper function. |
97 | $56 | $130 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
95 | $78 | $226 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
92 | $148 | $452 |
| Cardiac rhythm monitor programming Adjustment and configuration of an implanted cardiac rhythm monitoring device to ensure proper operation and data collection. |
89 | $47 | $91 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
88 | $58 | $152 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
84 | $1,222 | $4,000 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
81 | $52 | $105 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
76 | $5 | $40 |
| CT scan of heart for calcium evaluation A CT scan of the heart used to evaluate calcium levels in the blood vessels. |
68 | $84 | $223 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
54 | $141 | $304 |
| Pacemaker system programming Adjustment and testing of a multi-lead pacemaker to ensure proper function and settings. |
51 | $68 | $134 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
36 | $9 | $100 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
36 | $17 | $100 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
35 | $57 | $197 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
23 | $161 | $444 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
23 | $58 | $150 |
| Electrocardiogram, 1 to 3 leads A test that records the electrical activity of the heart using one to three electrodes placed on the body. |
16 | $5 | $13 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
14 | $57 | $152 |
| Removal and replacement of dual lead permanent pacemaker This procedure involves removing an existing permanent pacemaker with two leads and replacing it with a new device. It is performed to update or repair the heart rhythm management system. |
13 | $267 | $729 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
11 | $1 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
38.8% high complexity
16.2% medium
44.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,309
Total received (2018-2024)
Avg $1,473/year across 7 years
Top 27% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
375
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,309 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,758
2023
$1,451
2022
$1,401
2021
$878
2020
$890
2019
$1,870
2018
$2,062
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,109
AstraZeneca Pharmaceuticals LP
$182
Novartis Pharmaceuticals Corporation
$138
Merck Sharp & Dohme LLC
$87
PFIZER INC.
$73
Amgen Inc.
$62
SCPHARMACEUTICALS INC.
$48
Impulse Dynamics (USA) Inc.
$31
AltaThera Pharmaceuticals LLC
$29
Top 3 companies account for 81.3% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$4,956
Medtronic Vascular, Inc.
$2,215
Amgen Inc.
$733
Merck Sharp & Dohme LLC
$445
Novartis Pharmaceuticals Corporation
$276
AstraZeneca Pharmaceuticals LP
$256
CVRx, Inc.
$220
Merck Sharp & Dohme Corporation
$151
PFIZER INC.
$132
Gilead Sciences, Inc.
$114
iRhythm Technologies, Inc.
$100
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$69
Kowa Pharmaceuticals America, Inc.
$63
Akcea Therapeutics, Inc.
$55
SANOFI-AVENTIS U.S. LLC
$51
Boston Scientific Corporation
$49
SCPHARMACEUTICALS INC.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Alnylam Pharmaceuticals Inc.
$40
E.R. Squibb & Sons, L.L.C.
$38
Bayer HealthCare Pharmaceuticals Inc.
$35
Impulse Dynamics (USA) Inc.
$31
AltaThera Pharmaceuticals LLC
$29
Esperion Therapeutics, Inc.
$27
Janssen Pharmaceuticals, Inc
$26
Kiniksa Pharmaceuticals, Ltd.
$25
Regeneron Healthcare Solutions, Inc.
$21
DAVOL INC.
$20
Daiichi Sankyo Inc.
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Amarin Pharma Inc.
$13
Top 3 companies account for 76.7% of all-time payments
Associated products mentioned in payments ›
ALLURE · ALLURE QUADRA · ANDEXXA · ARISTA AH · ASSURITY · AVEIR · Advisa · Advisor Catheter · Allure Quadra RF CRT Pacemaker · Arcalyst · Assurity Pacemaker · Attain · Azure · BELSOMRA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CONFIRM RX · CRT-Ds · CareLink · CareLink Express · Claria MRI · Compia MRI · Confirm Rx · CoreValve Evolut · Corlanor · ELIQUIS · ENSITE · ENTRESTO · Ellipse ICD · FARXIGA · FORTIFY ASSURA · FUROSCIX · Fortify Assura · GALLANT · ICDs · INJECTAFER · JANUVIA · JARDIANCE · JOT DX · Kerendia · LEQVIO · LOKELMA · LifeVest · Livalo · MERLIN@HOME · Micra · MitraClip System · NEXLETOL · ONPATTRO · Optimizer · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QUADRA ALLURE MP · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Repatha · Reveal LINQ · Sotalol Hydrochloride · TEGSEDI · TENDRIL · TYRX · TactiCath Quartz CFA Catheter · UNIFY ASSURA · Unify Assura CRT Defibrillator · VERQUVO · VYNDAQEL · Vascepa · Visia AF · WAINUA · WATCHMAN · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
30
Per 100K population
3.3
County median income
$67,660
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nalos is a remote & electrophysiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nalos experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Nalos performed 1,302 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nalos receive payments from pharmaceutical companies?
Yes. Dr. Nalos received a total of $10,309 from 31 companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nalos's costs compare to other cardiologists in Bakersfield?
Dr. Nalos's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nalos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Bakersfield
Browse cardiologists in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology